Because of a lapse in government funding, the information on this website may not be up to date transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

NCI Dictionary of Cancer Terms

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Dictionary of Cancer Terms features 8,188 terms related to cancer and medicine.

We offer a widget that you can add to your website to let users look up cancer-related terms. Get NCI’s Dictionary of Cancer Terms Widget.

Browse:
granulocyte colony-stimulating factor
(GRAN-yoo-loh-SITE KAH-luh-nee-STIM-yoo-LAY-ting FAK-ter)
A drug used to treat neutropenia (a condition in which there is a lower-than-normal number of white blood cells) caused by some types of chemotherapy. It is used to help prevent infection in patients with certain types of cancer. It is also used to treat chronic neutropenia and to prepare the blood for the collection of certain types of blood cells. Granulocyte colony-stimulating factor is also used to help prevent damage to the bone marrow in patients who were exposed to very high doses of certain types of radiation. Granulocyte colony-stimulating factor helps the body make more white blood cells. It is a type of colony-stimulating factor. Also called filgrastim, G-CSF, Neupogen, and Zarxio.